Pharnext appoints Chief Operating Officer
Pharnext SA announced the appointment of Amit Kohli, a senior healthcare industry executive, as Chief Operating Officer (COO). Mr. Kohli is responsible for leading Pharnext's corporate strategy and operations.
"Amit is a seasoned leader with over 20 years' experience in the healthcare industry, and we are thrilled he is joining Pharnext," said Prof. Daniel Cohen, M.D., Ph.D., Co-Founder and Chief Executive Officer of Pharnext. "We are deeply impressed with Amit's results-oriented track record, and his ability to drive business strategy and operations across the pharma, medtech and clinical diagnostics sectors. We believe Pharnext will greatly benefit from his extensive cross-functional leadership experience especially as our first-in-class orphan drug, PXT3003, for the treatment of Charcot-Marie-Tooth disease type 1A, is set to release Phase 3 trial data before the end of 2018."
Before joining Pharnext, Mr. Kohli was a General Manager of clinical diagnostics at Eurofins in Brussels, where he lead business expansion across Europe and the Middle East. Prior to that, he was a Regional Business Director at Becton Dickinson, focused on delivering business growth in Russia, Turkey, the Middle East and Africa. Mr. Kohli also held a number of leadership roles at Sanofi in sales, marketing, finance, supply chain and manufacturing. During his decade and a half with Sanofi, Mr. Kohli lived and worked in Mumbai, Frankfurt, London, Helsinki and Paris.
Mr. Kohli earned an M.B.A. from the Management Development Institute (MDI) Gurgaon, in India, and a Bachelor of Engineering from the University of Pune in India.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
